Literature DB >> 9448698

Variation in the glycoprotein and VP35 genes of Marburg virus strains.

A Sanchez1, S G Trappier, U Ströher, S T Nichol, M D Bowen, H Feldmann.   

Abstract

Marburg virus, the prototype of the family Filoviridae, differs genetically, serologically, and morphologically from Ebola viruses. To better define the genetic variation within the species, VP35 and glycoprotein (GP) genes of representative human isolates from four known episodes of Marburg virus hemorrhagic fever were analyzed. The percentage nucleotide differences in the GP gene coding regions of Marburg viruses (0.1-21%) was nearly equal to the percentage amino acid changes (0-23%), while the percentage nucleotide differences in VP35 coding regions (0.3-20.9%) were higher than the percentage amino acid changes (0.9-6.1%), indicating a greater number of nonsynonymous changes occurring in the GP gene. The higher variation in the GP gene and the corresponding protein, especially those changes in the variable middle region of the GP, suggests that the variability may be the result of responses to natural host pressures. Analysis of the GP gene open reading frame shows a nonrandom distribution of nonsynonymous mutations that may indicate positive Darwinian selection is operating within the variable region. A heptad repeat region and an adjoining predicted fusion peptide are found in the C-terminal third of Marburg virus GPs, as has been previously shown for Ebola virus, and are similar to those found in transmembrane glycoproteins of retroviruses, paramyxoviruses, coronaviruses, and influenza viruses. Comparative analyses showed that there are two lineages within the Marburg virus species of filoviruses. The most recent isolate from Kenya (1987) represents a separate genetic lineage within the Marburg virus species (21-23% amino acid difference). However, this lineage likely does not represent a separate Marburg subtype, as the extent of divergence is less than that separating Ebola virus subtypes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9448698      PMCID: PMC7172989          DOI: 10.1006/viro.1997.8902

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  28 in total

1.  Glycosylation and oligomerization of the spike protein of Marburg virus.

Authors:  H Feldmann; C Will; M Schikore; W Slenczka; H D Klenk
Journal:  Virology       Date:  1991-05       Impact factor: 3.616

2.  Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins.

Authors:  P Chambers; C R Pringle; A J Easton
Journal:  J Gen Virol       Date:  1990-12       Impact factor: 3.891

3.  Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses.

Authors:  W R Gallaher
Journal:  Cell       Date:  1996-05-17       Impact factor: 41.582

4.  Core structure of gp41 from the HIV envelope glycoprotein.

Authors:  D C Chan; D Fass; J M Berger; P S Kim
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

5.  The nucleoprotein gene of Ebola virus: cloning, sequencing, and in vitro expression.

Authors:  A Sanchez; M P Kiley; B P Holloway; J B McCormick; D D Auperin
Journal:  Virology       Date:  1989-05       Impact factor: 3.616

6.  [On the etiology of an unknown human infection originating from monkeys].

Authors:  R Siegert; H L Shu; W Slenczka; D Peters; G Müller
Journal:  Dtsch Med Wochenschr       Date:  1967-12-22       Impact factor: 0.628

7.  Marburg-virus disease in Kenya.

Authors:  D H Smith; B K Johnson; M Isaacson; R Swanapoel; K M Johnson; M Killey; A Bagshawe; T Siongok; W K Keruga
Journal:  Lancet       Date:  1982-04-10       Impact factor: 79.321

8.  Identification and analysis of Ebola virus messenger RNA.

Authors:  A Sanchez; M P Kiley
Journal:  Virology       Date:  1987-04       Impact factor: 3.616

9.  GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases.

Authors:  V E Volchkov; S Becker; V A Volchkova; V A Ternovoj; A N Kotov; S V Netesov; H D Klenk
Journal:  Virology       Date:  1995-12-20       Impact factor: 3.616

10.  Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya.

Authors:  E D Johnson; B K Johnson; D Silverstein; P Tukei; T W Geisbert; A N Sanchez; P B Jahrling
Journal:  Arch Virol Suppl       Date:  1996
View more
  21 in total

1.  Development and evaluation of a simple assay for Marburg virus detection using a reverse transcription-loop-mediated isothermal amplification method.

Authors:  Yohei Kurosaki; Allen Grolla; Aiko Fukuma; Heinz Feldmann; Jiro Yasuda
Journal:  J Clin Microbiol       Date:  2010-04-26       Impact factor: 5.948

2.  Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine.

Authors:  Kathleen M Daddario-DiCaprio; Thomas W Geisbert; Joan B Geisbert; Ute Ströher; Lisa E Hensley; Allen Grolla; Elizabeth A Fritz; Friederike Feldmann; Heinz Feldmann; Steven M Jones
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses.

Authors:  S Y Chan; R F Speck; M C Ma; M A Goldsmith
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Antibody-dependent enhancement of Marburg virus infection.

Authors:  Eri Nakayama; Daisuke Tomabechi; Keita Matsuno; Noriko Kishida; Reiko Yoshida; Heinz Feldmann; Ayato Takada
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

5.  Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola.

Authors:  Jonathan S Towner; Marina L Khristova; Tara K Sealy; Martin J Vincent; Bobbie R Erickson; Darcy A Bawiec; Amy L Hartman; James A Comer; Sherif R Zaki; Ute Ströher; Filomena Gomes da Silva; Fernando del Castillo; Pierre E Rollin; Thomas G Ksiazek; Stuart T Nichol
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

6.  Characterization of the receptor-binding domain of Ebola glycoprotein in viral entry.

Authors:  Jizhen Wang; Balaji Manicassamy; Michael Caffrey; Lijun Rong
Journal:  Virol Sin       Date:  2011-06-12       Impact factor: 4.327

Review 7.  A Forgotten Episode of Marburg Virus Disease: Belgrade, Yugoslavia, 1967.

Authors:  Elizabeta S Ristanović; Nenad S Kokoškov; Ian Crozier; Jens H Kuhn; Ana S Gligić
Journal:  Microbiol Mol Biol Rev       Date:  2020-05-13       Impact factor: 11.056

8.  Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodies.

Authors:  Eri Nakayama; Ayaka Yokoyama; Hiroko Miyamoto; Manabu Igarashi; Noriko Kishida; Keita Matsuno; Andrea Marzi; Heinz Feldmann; Kimihito Ito; Masayuki Saijo; Ayato Takada
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

9.  The Role of the Charged Residues of the GP2 Helical Regions in Ebola Entry().

Authors:  Haiqing Jiang; Jizhen Wang; Balaji Manicassamy; Santhakumar Manicassamy; Michael Caffrey; Lijun Rong
Journal:  Virol Sin       Date:  2009-04       Impact factor: 4.327

10.  Relaxed selection and the evolution of RNA virus mucin-like pathogenicity factors.

Authors:  Joel O Wertheim; Michael Worobey
Journal:  J Virol       Date:  2009-02-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.